NeuPath Health Announces Consulting Agreement to Support Leadership Changes
TORONTO–(BUSINESS WIRE)–NeuPath Health Inc. (TSXV: NPTH), (“NeuPath” or the “Company”), owner and operator of a network of clinics providing cutting-edge treatments for chronic pain, today announced the conclusion a consultation agreement with one of the directors of the Company; Aries Grishanth.
To support the accelerated growth strategy and recently announced leadership changes, NeuPath has entered into a consulting agreement with Grishanth Ram in an advisory capacity to support the Executive Chairman in the transition to her new role. The duration of the consultancy contract is two months ending September 21, 2022.
Mr. Ram has been a member of NeuPath’s Board of Directors since June 25, 2020. Prior to joining the Board of Directors, Mr. Ram served as Chief Executive Officer of NeuPath from March 2018 to February 2019 and Executive Director of NeuPath. from February 2019 to December 2019. Mr. Ram will continue to serve on NeuPath’s Board of Directors for the duration of his consulting contract.
NeuPath is a vertically integrated healthcare provider that uses research, data-driven insights, technology and interdisciplinary care to help restore function for patients affected by chronic pain, spinal injuries, sports-related injuries and concussions. With participation in seventeen clinics in Ontario and Alberta, NeuPath is building a large-scale network to better serve patients across Canada. NeuPath focuses on transforming the hope of a better life into the reality of a more fully lived life.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICE PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE .